Positive two-year data from ALPS registry of LimFlow system published
Ngày 27/05/2020 08:56 | Lượt xem: 326

LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialisation (pDVA) system. Results were published online yesterday in the Journal of Endovascular Therapy and will also appear in the August print issue of the journal.

The ALPS Registry is the largest study to date of no-option chronic limb-threatening ischaemia (CLTI) patients treated with the LimFlow system reporting mid- and long-term results.

“In this complex group of patients, pDVA using the LimFlow device has shown to be feasible and safe with high technical success and good amputation-free survival at six months up to 24 months coupled with good wound healing,” said the paper’s lead author, Andrej Schmidt, head of the Angiology CathLab at Leipzig University Hospital, Leipzig, Germany. “In selected patients with no-option CLTI, pDVA is a safe and effective treatment to prevent amputation and heal wounds.”

“Patients with this disease suffer with chronic ulcers, often including gangrene, recurrent pain, and a very poor quality of life. CLTI is associated with poor mid- and long-term survival, and no-option patients often face the worst outcomes,” said Roberto Ferraresi, chief of the Peripheral Interventional Unit at the San Carlo Clinic, Milan, Italy, co-author of the paper, and a pioneer in the interventional treatment of CLTI. “These patients desperately need an option to avoid amputation and improve their life, and LimFlow offers a very promising alternative for them.”

The ALPS Registry is a multicentre, retrospective study conducted at centres in Alkmaar, the Netherlands; Leipzig, Germany; Paris, France; and Singapore encompassing 32 end-stage—or “no-option”—CLTI patients.

All patients had non-healing wounds on the target foot and no arterial target for surgical or endovascular revascularisation. Among them, 66% had diabetes, 53% had renal insufficiency, and 16% were dialysis dependent. The majority of patients had experienced failed prior attempts at revascularisation.

The registry reported major amputation-free survival of 84%, 71%, and 67%, respectively, at six months, one year and two years. Additionally, a positive trend of successful wound healing was demonstrated, with 73% of wounds completely healed at two years. Technical success was 97%.

When all other therapeutic options have been exhausted and a CLTI patient is facing major amputation, the minimally-invasive LimFlow system is designed to bypass blocked arteries in the leg and deliver oxygenated blood back into the foot via the veins. For many patients, restoring perfusion in the lower limbs resolves chronic pain, improves quality of life, enables wound healing and prevents major amputation.

“It is very gratifying to see these durable results being demonstrated by the LimFlow system in a real-world setting with consecutive patients,” said LimFlow CEO Dan Rose. “For these no-option patients, the next intervention for their leg was going to be major amputation, with the associated morbidity and high mortality risk that comes with amputation. Instead, two years later, the vast majority of patients are alive, with almost three-quarters of them experiencing completely healed wounds. This registry adds to the building clinical evidence that LimFlow therapy is an effective solution for no-option patients.”

Source VascularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua google bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua twitter bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua MySpace bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua LinkedIn bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua stumbleupon bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua icio bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua digg bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua yahoo bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua yahoo bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua yahoo bài: Positive two-year data from ALPS registry of LimFlow system published Chia sẽ qua yahoo bài: Positive two-year data from ALPS registry of LimFlow system published

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP